Dr. Catherine L. Kuntz, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- Perelman School of Med at the University of Pennsylvania (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 521
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Perelman School of Med at the University of Pennsylvania
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
PA license MD074248L
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Main Line Hospital Lankenau Wynnewood, PA
- Paoli Hospital Paoli, PA
- Bryn Mawr Hospital Bryn Mawr, PA
- Riddle Memorial Hospital Media, PA
Medical groups
- Pulmonology Associates Inc (18 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 521
- Services billed
- 2,043
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 388 | 139 |
| Test to measure expiratory airflow and volume | 290 | 180 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 221 | 137 |
| Established patient office or other outpatient visit, 40-54 minutes | 182 | 98 |
| Established patient office or other outpatient visit, 30-39 minutes | 143 | 105 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 142 | 89 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 101 | 96 |
| Evaluation of use of breathing device | 57 | 47 |
| Test to examine how well the lungs exchange gases | 43 | 43 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 36 | 36 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Wynnewood, PA | 299 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Wynnewood, PA | 257 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Wynnewood, PA | 114 |
| Prednisone Other prescribers in Wynnewood, PA | 97 |
| Montelukast Sodium Other prescribers in Wynnewood, PA | 76 |
| Fluticasone Propionate Other prescribers in Wynnewood, PA | 69 |
| Fluticasone-Salmeterol (fluticasone propion/salmeterol) Other prescribers in Wynnewood, PA | 67 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Wynnewood, PA | 58 |
| Budesonide-Formoterol Fumarate (budesonide/formoterol fumarate) Other prescribers in Wynnewood, PA | 40 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Wynnewood, PA | 34 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 15 companies reported 82 payments worth $2,034 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $842 |
|---|---|
| GlaxoSmithKline, LLC. | $396 |
| Regeneron Healthcare Solutions, Inc. | $232 |
| Verona Pharma, Inc. | $144 |
| Viatris Specialty LLC | $141 |
| Genentech USA, Inc. | $47.03 |
| Insmed, Inc. | $42.27 |
| Philips North America LLC | $33.21 |
| Food and Beverage | $2,034 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.